Advisor Group’s Counterpath Corp CPAH Stock Holding History

Advisor Group’s Portfolio CPAH Stock Details CPAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-40	Closed	–	–	5234
2017 Q4	$0	Sell	40 -150	-79%	-$386	﹤0.01%	5234
2017 Q3	$0	Hold	190	–	–	﹤0.01%	5123
2017 Q2	$0	Hold	190	–	–	﹤0.01%	5079
2017 Q1	$0	Hold	190	–	–	﹤0.01%	4961
2016 Q4	$0	Hold	190	–	–	﹤0.01%	4815
2016 Q3	$0	Hold	190	–	–	﹤0.01%	4825
2016 Q2	$0	Buy	+190	New	+$427	﹤0.01%	4649

Other funds holding CPAH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Advisor Group's CPAH Position: Q1 2018 in Review

Advisor Group sold out of Counterpath Corp (CPAH) in Q1 2018, closing a stake of 40 shares.

Advisor Group first reported a position in CPAH in Q2 2016 and held it in 7 quarters. The position peaked at $0 in Q4 2017. 8 funds tracked by Wall St. Rank hold CPAH as of Q1 2018.

Advisor Group reported no remaining Counterpath Corp position as of Q1 2018 after selling out during the quarter.
Advisor Group sold 40 Counterpath Corp shares in Q1 2018.
Advisor Group first reported a position in Counterpath Corp in Q2 2016 and held it in 7 quarters.
Advisor Group's Counterpath Corp position peaked at $0 in Q4 2017.
8 funds tracked by Wall St. Rank held Counterpath Corp as of Q1 2018.

Based on Advisor Group's 13F filing for Q1 2018, filed 15 May 2018.